Bioceres Crop Solutions (BIOX)

• Market cap: $270M
• 1 day: -2.41%
• 5 days: 6.70%
• 1 month: 13.20%
• 3 months: -33.63%
• 6 months: -43.26%
• Year to date: -33.63%
• 1 year: -64.66%
• 5 years: -3.67%
• 10 years: -53.54%
• Sector: Materials
• Industry: Agricultural Chemicals

About: Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

Employees: 983

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

1,415% more call options, than puts

Call options by funds: $606K | Put options by funds: $40K

40% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 10

2.18% less ownership

Funds ownership: 22.07% [Q3] → 19.89% (-2.18%) [Q4]

11% less funds holding

Funds holding: 47 [Q3] → 42 (-5) [Q4]

30% less capital invested

Capital invested by funds: $109M [Q3] → $76M (-$33.2M) [Q4]

31% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 13

33% less funds holding in top 10

Funds holding in top 10: 3 [Q3] → 2 (-1) [Q4]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $6.50 46% upside
• Avg. target: $8.83 98% upside
• High target: $12 169% upside

3 analyst ratings

• positive: 3 100%
• neutral: 0 0%
• negative: 0 0%

Canaccord Genuity Austin Moeller 18% 1-year accuracy 10 / 56 met price target	46% upside $6.50	Buy Maintained	13 Feb 2025
Lake Street Ben Klieve 21% 1-year accuracy 3 / 14 met price target	79% upside $8	Buy Maintained	7 Feb 2025
Oppenheimer Kristen Owen 34% 1-year accuracy 14 / 41 met price target	169% upside $12	Outperform Maintained	28 Jan 2025